Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06706856 · ClinicalTrials.gov registry record
Quantitative Ultrasound to Assess Steatotic Liver Disease in Children
A clinical trial of MASLD and MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT06706856: Recruiting study of MASLD and MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, sponsored by University of California, San Diego.
NCT06706856 is a study of MASLD and MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 120 participants, above the 96-participant average among 7 other MASLD trials with a reported enrollment target (25% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06706856, a study of MASLD and MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is being conducted to find out more about advanced ultrasound techniques to non-invasively evaluate liver disease in children. The investigators are developing advanced techniques for analyzing ultrasound data and images of the liver, and they will compare it to other established methods used to evaluate the liver, including liver MRI. The investigators plan to develop and test the advanced analysis techniques using conventional full-size ultrasound machines and, if possible, small handheld devices. Our goals are: * To assess the accuracy of the advanced ultrasound analysis techniques in children * To implement and assess these advanced technique on small handheld ultrasound devices, if possible
Primary Outcome
We plan to develop and evaluate models for estimating liver fat fraction and classifying the presence or absence of steatotic liver disease using QUS data.
Conditions Studied
Interventions
- OTHER Blood draw
- OTHER Questionnaires
- DIAGNOSTIC_TEST MR exam
- DIAGNOSTIC_TEST US exam
- OTHER Physical measurements
Study Locations (1)
California
- University of California San Diego - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-09-23 |
| Est. Completion | 2029-06-30 |
What NCT06706856 shows while recruiting
NCT06706856 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, above the 96-participant average among 7 other MASLD trials with a reported enrollment target (25% higher).
The record links to 2 conditions, with MASLD appearing as the primary indexed condition, and to 5 interventions - of which Blood draw is the first listed.
NCT06706856 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06706856 about?
NCT06706856 is a clinical study titled "Quantitative Ultrasound to Assess Steatotic Liver Disease in Children". This research study is being conducted to find out more about advanced ultrasound techniques to non-invasively evaluate liver disease in children. The investigators are developing advanced techniques for analyzing ultrasound data and images of the liver, and they will compare it to other established...
What is the current status of trial NCT06706856?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2024-09-23. Estimated completion is 2029-06-30.
What conditions does trial NCT06706856 study?
This clinical trial studies the following conditions: MASLD, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease.
What interventions are being tested in trial NCT06706856?
The interventions under investigation include: Blood draw (OTHER), Questionnaires (OTHER), MR exam (DIAGNOSTIC_TEST), US exam (DIAGNOSTIC_TEST), Physical measurements (OTHER).
Who is sponsoring clinical trial NCT06706856?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06706856 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for MASLD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
-
Endoscopic Ultrasound Shear Wave Elastography Study
RECRUITING
-
Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
RECRUITING · Early Phase 1
-
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
RECRUITING · NA
-
Digoxin In NASH (CODIN)
RECRUITING · Phase 2
-
Influence of Metabolic Syndrome on Endogenous Oxalate Synthesis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI